Menu
  • Video
  • Audio
  • Images
  • Collections
  • About
Sign in
ASRS A project from the American Soceity of Retina Specialists
Share feedback      Sign in
ASRS Multimedia Library
ASRS A project from the American Society of Retina Specialists
Search by condition, keyword, or author name
  • Video
  • Audio
  • Images
  • Collections
  • About
  1. Collections
  2. Annual Meeting Talks

Sign in to view content

Sign in

Number of Injections and Time to Dry Analysis of Brolucizumab Versus Aflibercept in Patients With Neovascular AMD: 96-Week Data From HAWK and HARRIER

  • Carl D. Regillo, MD
  • Video
  • Published 2020

Related

  • High-dose Aflibercept Therapy in nAMD and DME Eyes With Suboptimal Response to Standard Dose of Anti-VEGF Therapy: A Retrospective Analysis

    Jared S. Nielsen, MD, MBA

    Annual Meeting Talks

    2020

  • Association Between DRSS Changes and Visual/ Anatomic Outcomes in Patients With Moderately Severe to Severe NPDR: Post Hoc Analysis of PANORAMA

    Diana V Do, MD, FASRS

    Annual Meeting Talks

    2022

  • Treatment of CRVO: SCORE2 Sub-analysis

    Michael S. Ip, MD

    Updates from the Field

    2019

Category: AMD-Neovascular

  • Aflibercept
  • Sustained retinal dryness
  • Injection number
  • Treatment burden

See more

  • Annual Meeting Talks
  • Carl D. Regillo, MD
  • ASRS Multimedia Library
  • Video
  • Audio
  • Images
  • Collections
American Society of Retina Specialists20 North Wacker Drive, Suite 2030,Chicago, Illinois 60606(312) 578-8760 phoneinfo@asrs.org
© 2025 The American Society of Retina Specialists. All rights reserved. Privacy statement. Terms of use.